This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of drugs targeting central nervous system disorders, such as antidepressants and antipsychotics. Its chiral structure makes it valuable for creating enantiomerically pure compounds, which are often essential for achieving desired therapeutic effects with minimal side effects. Additionally, it is explored in the development of novel compounds for treating chronic pain and neurodegenerative diseases due to its ability to interact with specific receptors in the brain. Its fluorinated aromatic ring enhances its metabolic stability and bioavailability, making it a promising candidate for drug design.